Skip to main content

Peer Review reports

From: Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma

Original Submission
23 Aug 2018 Submitted Original manuscript
5 Dec 2018 Author responded Author comments - Houda Bahig
27 Oct 2018 Reviewed Reviewer Report - Harold Lau
31 Oct 2018 Reviewed Reviewer Report - Christophe Le Tourneau
4 Nov 2018 Reviewed Reviewer Report - Jonathan D. Schoenfeld
Resubmission - Version 2
5 Dec 2018 Submitted Manuscript version 2
17 Dec 2018 Reviewed Reviewer Report - Harold Lau
6 Dec 2018 Reviewed Reviewer Report - Jonathan D. Schoenfeld
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
2 Jan 2019 Editorially accepted
14 Jan 2019 Article published 10.1186/s12885-019-5266-4

You can find further information about peer review here.

Back to article page